Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

54 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Making the Case for All-Oral, Shorter Regimens for Children with Drug-Resistant Tuberculosis.
Patankar S, Cruz AT, Douglas-Jones B, Garcia-Prats A, Kay A, Reuter A, Schaaf HS, Seddon JA, Sharma S, Starke J, Tommasi M, Triasih R, Furin JJ. Patankar S, et al. Among authors: furin jj. Am J Respir Crit Care Med. 2023 Jul 15;208(2):130-131. doi: 10.1164/rccm.202304-0670VP. Am J Respir Crit Care Med. 2023. PMID: 37276531 Free PMC article. No abstract available.
The Lancet Respiratory Medicine Commission: 2019 update: epidemiology, pathogenesis, transmission, diagnosis, and management of multidrug-resistant and incurable tuberculosis.
Dheda K, Gumbo T, Maartens G, Dooley KE, Murray M, Furin J, Nardell EA, Warren RM; Lancet Respiratory Medicine drug-resistant tuberculosis Commission group. Dheda K, et al. Lancet Respir Med. 2019 Sep;7(9):820-826. doi: 10.1016/S2213-2600(19)30263-2. Lancet Respir Med. 2019. PMID: 31486393 Review.
Closing the policy-practice gap for tuberculosis preventive treatment.
Casenghi M, Furin J, Sekadde MP, Sharma S, Marais BJ. Casenghi M, et al. Lancet Child Adolesc Health. 2024 May;8(5):315-317. doi: 10.1016/S2352-4642(24)00018-X. Epub 2024 Mar 21. Lancet Child Adolesc Health. 2024. PMID: 38522447 No abstract available.
Diagnostics to support the scaling up of shorter, safer tuberculosis regimens.
Branigan D, Denkinger CM, Furin J, Heitkamp P, Deborggraeve S, van Gemert W, Herrera R, Kondratyuk S, McKenna L, Ndjeka N, Omar SV, Pai M. Branigan D, et al. Lancet Microbe. 2023 Oct;4(10):e758-e760. doi: 10.1016/S2666-5247(23)00217-3. Epub 2023 Jul 31. Lancet Microbe. 2023. PMID: 37536352 Free article. No abstract available.
Balancing adjunctive therapy for tuberculosis treatment.
Ndjeka N, Furin J. Ndjeka N, et al. Lancet Infect Dis. 2023 Jul;23(7):771-772. doi: 10.1016/S1473-3099(23)00136-6. Epub 2023 Mar 23. Lancet Infect Dis. 2023. PMID: 36966798 No abstract available.
Tuberculosis recovery in Georgia: implementing more by 24.
Kiria N, Lomtadze N, Solomonia N, Aspindzelashvili R, Danelia M, Gabisonia I, Janjgava M, Khonelidze I, Kipiani M, Tukvadze N, Blumberg HM, Kempker RR, Furin J, Avaliani Z. Kiria N, et al. Lancet Infect Dis. 2023 Aug;23(8):893-894. doi: 10.1016/S1473-3099(22)00689-2. Epub 2022 Oct 27. Lancet Infect Dis. 2023. PMID: 36354031 Free PMC article. No abstract available.
54 results